The Wall Street Journal’s Venture Capital Pro quoted a recent biopharma report from William Blair’s equity capital markets team, noting the uptick in activity for PIPEs among biopharma companies in 2023.

Investment Banking
The Wall Street Journal’s Venture Capital Pro quoted a recent biopharma report from William Blair’s equity capital markets team, noting the uptick in activity for PIPEs among biopharma companies in 2023.
Stay up-to-date with the latest William Blair news and insights
William Blair announced today the addition of Robert Engelhardt as a director in the firm’s Tech Enabled Services team. Based in Frankfurt, Engelhardt will provide comprehensive advisory resources to companies and financial sponsors throughout the DACH region and across Europe.
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures